Abbott Norvir medical cost savings roughly offset cost of protease inhibitor -- MedTap study.
Executive Summary
ABBOTT NORVIR MEDICAL COST OFFSETS ALMOST EQUAL ANNUAL DRUG PRICE in a cost analysis conducted by Arlington, Va.-based MedTap International and the University of North Carolina. The analysis presented at the July 11 International Conference on AIDS in Vancouver showed that adding Norvir (ritonavir) to standard antiviral therapy in advanced HIV led to a reduction of $6,382 in annual medical costs per patient. The wholesale acquisition cost of Norvir is about $6,500 per year.